Genenta Science SpA - ADR
NASDAQ:GNTA 3:59:19 PM EDT
Search For a Symbol
Genenta Science SpA - ADR Stock, NASDAQ:GNTA
Via Olgettina No. 58, Milan, Milan 20132
Number of Employees: 9
Genenta Science SpA is an early-stage company, which engages in the development of first-in-class cell and gene cancer therapies. Its lead product candidate, Temferon, was developed using its platform and carries an interferon-alpha payload. The company was founded by Pierluigi Paracchi, Luigi Naldini and Bernhard Gentner on July 24, 2014 and is headquartered in Milan, Italy.